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Abstract
Background: Foxn1
D/D mutant mice have a specific defect in thymic development, characterized by a block in TEC
differentiation at an intermediate progenitor stage, and blocks in thymocyte development at both the DN1 and DP cell
stages, resulting in the production of abnormally functioning T cells that develop from an atypical progenitor population. In
the current study, we tested the effects of these defects on thymic selection.
Methodology/Principal Findings: We used Foxn1
D/D; DO11 Tg and Foxn1
D/D; OT1 Tg mice as positive selection and Foxn1
D/
D; MHCII I-E mice as negative selection models. We also used an in vivo system of antigen-specific reactivity to test the
function of peripheral T cells. Our data show that the capacity for positive and negative selection of both CD4 and CD8 SP
thymocytes was reduced in Foxn1
D/D mutants compared to Foxn1
+/D control mice. These defects were associated with
reduction of both MHC Class I and Class II expression, although the resulting peripheral T cells have a broad TCR Vb
repertoire. In this deficient thymic environment, immature CD4 and CD8 SP thymocytes emigrate from the thymus into the
periphery. These T cells had an incompletely activated profile under stimulation of the TCR signal in vitro, and were either
hypersensitive or hyporesponsive to antigen-specific stimulation in vivo. These cell-autonomous defects were compounded
by the hypocellular peripheral environment caused by low thymic output.
Conclusions/Significance: These data show that a primary defect in the thymic microenvironment can cause both direct
defects in selection which can in turn cause indirect effects on the periphery, exacerbating functional defects in T cells.
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Introduction
The thymus is the primary site of T cell development. In the
thymus, heterogeneous thymic epithelial cells (TECs) and other
stromal cells including fibroblasts, dendritic cells, and macrophag-
es constitute a 3-dimensional space that provides a unique
microenvironment for the differentiation, proliferation, and
maturation of T cells. During differentiation, T cells undergo
VDJ recombination generating a diverse repertoire of TCRs.
Thymic positive selection ensures the differentiation and matura-
tion of thymocytes expressing a self-restricted TCR; negative
selection then removes those thymoctyes that have dangerously
high reactivity to self [1]. The resulting T cells migrate out of the
thymus resulting in a diverse repertoire of T cells that are able to
respond to foreign peptides while remaining tolerant to self-
peptides. The positive selection of CD4 and CD8 T cells is
restricted by MHCII and MHCI respectively. The development of
TCRab CD4 T cells can be typically supported by MHCII
expressing TECs, while CD8 T cells can be supported by MHCI
signals from TECs and other stromal cells in thymus [2,3,4,5,6].
The thymic medulla has been shown to be largely responsible for
negative selection [7,8]. In the cortico-medullary junction and
medulla, dendritic cells (DCs) play a major role in negative
selection; medullary TECs have also been reported to be sufficient
to drive this process [9].
The development, differentiation, and function of fetal TECs
are controlled by the forkhead-class transcription factor Foxn1
[10,11,12,13,14]. Foxn1 is widely if not ubiquitously expressed in
fetal TECs from a very early stage [13,15]. In the absence of
Foxn1 (i.e. in nude homozygotes), the thymic rudiment is formed,
but lymphoid progenitor cells (LPCs) fail to populate it [12,14,16].
In a severe hypomorphic allele, Foxn1
D, initial organogenesis
appears normal, but later thymocyte-dependent TEC differenti-
ation is blocked [2]. Thus, Foxn1 is required for both thymocyte-
dependent and -independent TEC differentiation. In the postnatal
thymus, Foxn1 expression is distributed in both cortex and medulla
[12,17,18]. We have recently reported that correct expression of
Foxn1 is also required to maintain the postnatal thymus, as
postnatal reduction of Foxn1 expression leads to a phenotype
resembling premature thymic involution [18]. Down regulation of
Foxn1 has also been implicated in initiating thymic involution
[19]. Thus, Foxn1 plays multiple crucial roles in the development
and maintenance of TECs throughout the lifespan of the
organism.
Foxn1
D/D mice have a very small thymus with abnormal
architecture lacking cortical and medullary domains, in which
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Thymocytes are specifically blocked at both the DN1 and DP
differentiation stages, express constitutively low TCR, and very
few SP thymocytes develop and immigrate into the periphery [10].
The resulting peripheral T cells have an atypical activated/
memory phenotype with low homeostatic potential and impaired
TCR signaling [20]. T regulatory (Treg) cells are generated but
have reduced function, and T cells are hyper-responsive in both
allo- and auto- MRL assays in vitro [21]. These abnormal T cells
develop from CD117
2 atypical progenitors without passing
through the DN2 or DN3 stages, but directly develop into DN4
from DN1 cells in the postnatal thymus [20]. As these atypical
progenitors are normally present in the wild-type thymus, these
may represent a normal sub-population of T cells that may serve a
specific as yet unknown function in the normal T cell repertoire.
As these T cells also have constitutively low TCR expression, the
question of whether this abnormal microenvironment is promoting
normal positive and negative selection is also important to
understanding the mechanism by which these T cells are
generated.
In the current study, we investigated the processes of positive
and negative selection in Foxn1
D/D mutants. We show that TEC
expression of both MHC Class I and II are reduced significantly,
with MHC Class II expression affected more severely. We
generated Foxn1
D/D BALB/c (MHCII I-E molecule positive) mice,
and crossed Foxn1
D/D to the DO11.10 CD4 and OT1 CD8
restricted TCR transgenes. By focusing on the TCR Vb usage and
the phenotypes of CD4 and CD8 Tg cells in the thymus or
periphery of Foxn1
D/D mice, we analyzed the thymic negative and
positive selection and assayed SP thymocyte post-selection
maturation in the thymus. We also analyzed T cell responses to
specific antigens in vivo. Our results show that the Foxn1
D/D thymus
did not generally affect the diversity of the TCR Vb repertoire,
although the frequencies of specific Vb usage were highly variable
in the mutants compared to controls. However, thymic negative
selection was partially reduced and positive selection was
dramatically reduced for CD4 T cells, but relatively normal for
CD8 T cells. These T cells generated abnormal responses to
antigen-specific stimulation in vivo. At least part of this abnormal
response was secondary to the previously reported memory-like
phenotype of T cells after lymphopenia-induced proliferation and
reduced Treg cell function in the Foxn1
D/D periphery [20]. Thus,
the peripheral T cell phenotype in the Foxn1
D/D mutants is the
result of both direct effects of abnormal selection within the
thymus, compounded by secondary effects of low T cell output
and a hypocellular peripheral environment.
Results
Peripheral T cells have broad but variable TCR Vb usage
in Foxn1
D/D mutant mice
Our previous data reported that T cells in Foxn1
D/D thymus
appear to develop from an atypical CD117
low/2 progenitor that
develops directly from DN1-DN4 stages, but did undergo TCR
VDJ recombination [20]. This result raises the question of whether
this atypical pathway generates a diverse TCR repertoire. Because
the number of SP thymocytes in the Foxn1
D/D thymus was too low
to be analyzed directly for TCR Vb usage, we assayed TCR Vb
expression on peripheral T cells (Fig. 1). We found that all TCR
Vb alleles were detected on both CD4 and CD8 Foxn1
D/D T cells.
Compared to TCRab
+ T cells in control mice, there was no
consistent difference in TCR Vb expression between the Foxn1
D/D
mutant mice and controls. The one exception was TCR Vb5,
which was significantly over-represented in the Foxn1
D/D CD4 T
cells. However, a high variability of TCR Vb expression was seen
in Foxn1
D/D individual mouse, compared to the consistent pattern
of TCR Vb expression on T cells from control mice. These results
indicated that while all TCR Vb alleles were utilized in the
Foxn1
D/D CD117
low/2 progenitor T cells, either the relative
frequency was variable, or the relative frequencies were skewed in
the periphery as a consequence of low thymic output and
differential expansion of specific Vb clones in response to a
hypocellular periphery.
Thymic negative selection was partially reduced in the
Foxn1
D/D mutant mice
Based on the expression of TCR Vb, we designed an
experiment to test thymic negative selection. Endogenous
superantigen–mediated TCR Vb T cell clonal deletion generally
occurs in mice that express an endogenous super-antigen and the
MHC-II I-E molecule [22]. The expression of Vb5.1 and Vb11
were clear on T cells in the Foxn1
D/D and Foxn1
+/D mice, both of
which are maintained on the C57BL/6 background (Fig. 2A),
because these mice failed to delete them due to lack of MHCII I-E
molecules on TECs. In BALB/c mice, which express the MHCII
I-E molecule, Vb5.1 and Vb11 bearing T cells are deleted (Fig. 2A,
B, D) [22]. We therefore backcrossed the C57BL/6 I-E
2 Foxn1
D/D
mice with BALB/c (I-E
+) mice, generating BALB/c (I-E
+)
Foxn1
D/D mice after more than 5 generations. On the BALB/c
genetic background, the expression of Vb5.1 and Vb11 was
greatly reduced in BALB/c Foxn1
+/D control mice, with around
90% of Vb5.1 and Vb11 bearing cells deleted (Fig. 2B-E, Table 1).
However only around 60% of Vb5.1 and Vb11 bearing cells were
deleted in the Foxn1
D/D mutant mice on this genetic background.
These data showed that although the thymic environment was
completely disorganized with lack of cortico-medullary junction
and medulla, thymic negative selection did occur in the Foxn1
D/D
thymus, although with reduced efficiency. Because the percentage
of MHC II
+CD45
+CD11c
+ DCs was higher in total thymic
stromal cells in the Foxn1
D/D than in the Foxn1
+/D mice (data not
shown), these DCs may partially compensate for the mTEC
deficiency in the Foxn1
D/D thymus.
Positive selection for CD4 T cells was greatly reduced in
Foxn1
D/D thymus
To measure the positive selection of CD4
+ SP cells, we crossed
the Foxn1
D/D;I-E
+ mice with the DO11.10 CD4 restricted TCR
transgenic mice (BALB/c background) to generate Foxn1
D/D;I-
E
+;DO11.10 Tg mice (called Foxn1
D/D;DO11.10 below) [23].
Compared to Foxn1
+/D mice without the DO11.10 transgene, the
percentage of CD4 SP thymocytes was increased 4-fold in Foxn1
+/
D;DO11.10 mice (from 7.5% to 30.6%) (Fig. 3A, B), with around
93% of CD4
+ SP cells being Kj1-26
+ transgene-expressing T cells
(Fig. 3C). The number of total thymocytes was also increased
(Fig. 3D). In contrast, in Foxn1
D/D;DO11.10 mice the percentage
of CD4
+ SP thymocytes was not significantly increased compared
to Foxn1
D/D alone. Only 78% of CD4 cells were Kj1-26
+, and the
number of total thymocytes was not significantly changed (Fig. 3A,
B, C, D). In peripheral T cells of Foxn1
+/D;DO11.10 control mice,
the percentage of splenic CD4
+ T cells was increased 1.7 fold
compared to the non-transgenic mice, with 95% of them Kj1-26
+ .
However, in the Foxn1
D/D;I-E
+;DO11.10 mice, the percentage of
splenic CD4 T cell dropped dramatically down over 6 fold, and
only 47% were Kj1-26
+ cells (Fig. 3E, F, G, H). These results
indicated that the capability for positive selection of the DO11.10
transgenic TCR was reduced in the Foxn1
D/D mice. This
phenotype showed high variability based on the wide range in
Impaired Thymic Selection in Foxn1
D/D Mutant Mice
PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e15396percentage of Kj1-26
+ CD4 T cells in the Foxn1
D/D;DO11.10
mice. In addition, we found a low percentage of Kj1-26
+ CD4 T
cells in the periphery compared to that seen in the thymus of
Foxn1
D/D;DO11.10 mice, suggesting that the transgenic CD4
+ cells
might not survive well in the periphery of the Foxn1
D/D;DO11.10
mice.
Positive selection for CD8 T cells was partially reduced in
Foxn1
D/D thymus
To measure the positive selection of CD8
+ T cells, we crossed
the Foxn1
D/D mice with OT1 TCR transgenic mice, in which
thymocytes are restricted to development of CD8
+ T cells. Tg
CD8 T cells were identified by expression of TCR Vb5 and Va2.
In the thymus of Foxn1
+/D;OT1 mice, the percentage of CD8
+ SP
cells was increased 5.4 fold (from 3% to 16.2%) compared to
Foxn1
+/D mice without the transgene, and 94% of CD8
+ SP
thymocytes were transgene positive. In Foxn1
D/D;OT1 mice, the
percentage of CD8 SP thymocyte was increased 3 fold (from 2.1%
to 6.2%), and 81.9% CD8 SP thymocytes were CD8 Tg cells
(Fig. 4A, B, C). Compared to non-transgenic mice, the total
thymic cell number was reduced in the Foxn1
+/D;OT1 control
mice, but was unchanged in Foxn1
D/D;OT1 mice (Fig. 4D). For
peripheral T cell analysis, the results were similar to thymus,
except there was no significant difference in total cell number
between mice of different genotypes (Fig. 4E, F, G, H). These
results indicated that Foxn1
D/D;OT1 mice had a reduced capability
for producing CD8
+ OT1 transgenic T cells compared to the
Foxn1
+/D;OT1 control mice, although to a lesser extent than was
seen for positive selection of CD4+ T cells.
Reduced MHC expression in Foxn1
D/D TECs
The evidence for decreased positive and negative selection in
the Foxn1
D/D mutant thymus combined with our previous data
showing serious deficits in TEC differentiation and cortico-
medullary organization in these mutants suggested that MHC
expression could well be affected. MHC II
hi stromal cells were
almost completely absent from the Foxn1
D/D mutant thymus, and
the percentage of stromal cells expressing intermediate levels of
MHC II was variable in the mutants, although not significantly
different (Fig. 5). MHC I
hi cells were also reduced significantly,
although not as dramatically, while MHC I
lo were increased
proportionately. The difference in magnitude of the effects on
Class I and Class II MHC was consistent with the more severe
effect on the positive selection of CD4
+ SP cells in the Foxn1
D/D
mutants.
Maturation of SP thymocytes was delayed in Foxn1
D/D
mice and immature SP thymocytes migrate into the
periphery
In the postnatal thymus, SP thymocytes stay in the thymic
medulla after positive selection for 3 to 5 days for further
maturation [24,25]. We previously reported that the thymic
architecture was completely disorganized in the Foxn1
D/D mice,
with lack of cortico-medullary junction and medullary organiza-
Figure 1. TCR Vb usage in the peripheral T cells of Foxn1
D/D mutant mice. The peripheral cells from spleen and LNs were screened with TCR
Vb usage. The result shown was average volume from at least 5 individual samples. A and B show the percentage of expression of TCR Vbs on CD4
and CD8 T cells.
doi:10.1371/journal.pone.0015396.g001
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thymocytes do leave the thymus and colonize the periphery [20].
This raises the question of whether and how SP thymocytes
undergo maturation in this deficient environment. To address this
issue, we assayed expression of the maturation markers HSA and
Qa2 on adult peripheral T cells. As we have previously shown that
SP thymocytes in the Foxn1
D/D thymus are contaminated with
recirculated peripheral T cells reentering the very hypocellular
Foxn1
D/D thymus [10,20], we tracked the expression of these
markers on thymocytes from newborn through 28 days postnatal,
and compared them to Foxn1
+/D controls.
Figure 2. Thymic negative selection was partially reduced in the Foxn1
D/D mutant mice. Foxn1
D/D/BALB/c mice were generated by
backcrossing Foxn1
D/D mice (H-2
b,I E
-) to BALB/c (H-2
d,I E
+) for more than 5 generations. Before and after backcrossing, the expressions of Vb5.1 and
Vb11 were measured on CD4 T cells. A, histograms showing representative profiles of Vb5.1 and Vb11 expressions on gated CD4 T lymphocytes from
Foxn1
+/D, Foxn1
D/D and BALB/c mice. B and D, individual analyses of Vb5.1 and Vb11 expression on CD4 T cells from Foxn1
+/D, Foxn1
D/D and BALB/c
mice before backcrossing. C and E, individual analysis of the percentage of Vb5.1 and Vb11 from Foxn1
D/D mice after backcrossing. C/C: C57BL6
background (IE
2/IE
2); B/B: BALB/c background (IE
+/IE
+); B/C: BALB/c/C57BL6 (IE
+/IE
2). (*, p,0.05).
doi:10.1371/journal.pone.0015396.g002
Table 1. Deletion of peripheral TCR Vb5.1 and Vb11 CD4
+ T
cell clones after backcrossing Foxn1
D/D mice onto the BALB/c
genetic background.
Cell clone Vb 5.1 T cell Vb 11 T cell
Genotype +/DD /D +/DD /D
Background B/B B/C B/B B/C B/B B/C B/B B/C
% Deletion 88.9 90.2 61.1 67.5 90.1 86.2 60 61.2
doi:10.1371/journal.pone.0015396.t001
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D/D;DO11.10 Tg mice. Foxn1
D/D;DO11.10 and
Foxn1
D/D;DO11.10 Tg mice were generated by mating Foxn1
D/D BALB/c mice with DO11.10 CD4 TCR Tg mice, and then CD4 Tg T cells were
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thymocytes are HSA
hi, while in the spleen the vast majority of T
cells have down regulated HSA, and there is essentially no Qa2
expression in either population (Fig. 6A). By Day 14, over half of
SP thymocytes have down regulated HSA, and a few also have low
levels of Qa2. In contrast, over 50% of CD4 and over 80% of CD8
splenic T cells are Qa2
+, and virtually all are HSA negative
(Fig. 6B). This trend continues in the thymus such that 4 weeks of
age most thymic SP cells are HSA
loQa2
2, while most splenic T
cells are HSA
2Qa2
+ (Fig. 6C).
In the Foxn1
D/D mutants at all ages examined, both SP
thymocytes and splenic T cells showed differences in their HSA
and Qa2 profiles compared to controls. At the newborn stage, over
90% of thymocytes were HSA
hi, while over 50% of CD4 and 35%
of CD8 splenic T cells also showed this phenotype (Fig. 6A). At
Day 14, about twice as many SP thymocytes remained HSA
hi in
the mutants compared to controls, although the frequency of
HSA
loQa2
+ thymocytes was similar. However, in the spleen the
effect was much greater, with 40% of CD4 and 30% of CD8 T
cells remaining HSA
hi, and the percentage of Qa2
+ cells was
roughly half that of controls (Fig. 6B). Even at Day 28, roughly
15% of SP thymocytes and 5–7% of splenic T cells retained high
HSA levels, ten-fold that of control mice, and fewer splenic T cells
were Qa2
+ (Fig. 6C). Thus, down-regulation of HSA and up-
regulation of Qa2 on both CD4 and CD8 SP thymocytes and on
peripheral T cells were delayed in Foxn1
D/D mice.
One explanation for the presence of HSA
hi peripheral T cells is
that some immature Foxn1
D/D SP thymocytes might migrate out of
the thymus. Consisted with this possibility, we found that CD4
peripheral T cells from the Foxn1
D/D mice could not be completely
activated. Around 20% of CD4 cells from Foxn1
D/D mice could not
up-regulate the expression of CD25 or CD69 after stimulation
with anti-CD3 within 24 hours in vitro (Fig. 6D). Almost all
Foxn1
+/D CD4 cells were activated with the same stimulation. In
contrast, Foxn1
D/D CD8 SP cells were more similar to the profile of
the Foxn1
+/D CD8 cells, with almost complete activation.
Consistent with our previous results, Foxn1
D/D T cells had
constitutively high expression of CD44, so this was not a reliable
marker for activation status [21](Fig. 6D).
Foxn1
D/D peripheral CD4, CD8 T cells have different
responses to SEA super-antigen in vivo
We next assayed how these T cells responded to specific antigen
in the periphery. We first tested the response of TCR Vb T cell
clones to the super-antigen SEA in vivo. Before and after exposure
to SEA, the expression of Vb3 and Vb11 were measured in
individual mice. Because the frequency of Vb3 and Vb11 bearing
cells in individual Foxn1
D/D mice was quite variable, the
percentage change in Vb3/11 bearing cells in individual mice
was shown by the ratio of before and after injection. As expected,
the percentage of Vb3/11 bearing CD4 and CD8 T cells
increased 2–4 fold after exposure to SEA at day 2 post-injection
in the Foxn1
+/D mice, and then went down rapidly to the same or
even below the level seen before exposure (Fig. 7), similar to a
previous report [20]. However in the Foxn1
D/D mice, the Vb3-
bearing CD4 T cells showed a delayed but a stronger and longer
lasting response, with a 5-fold increase in percentage at day 6 after
SEA exposure, and then a slow decline. CD8 T cells also had a
delayed response although it was weaker than CD4 T cells, and
even weaker than Foxn1
+/D CD8 T cells (Fig. 7A). Both Foxn1
D/D
Vb11 bearing CD4 and CD8 cells had a delayed and weaker
response to SEA compared to the same cells in the Foxn1
+/D mice
(Fig. 7B). These data indicated that different Foxn1
D/D T cell
clones have different responses to the same antigen in vivo. Thus,
some clones might increase and some clones might be reduced in
response to the same antigen.
The thymus defects in the Foxn1
D/D mice result in very low SP
cell production and decreased T cell output from the thymus,
causing a hypocellular peripheral environment [10,20]. The
hypocellular periphery contributes to the peripheral T cell
phenotypes by promoting an activated/memory phenotype in
most T cells [20]. To distinguish whether the abnormal response
of Foxn1
D/D T cells was directly due to the developmental defect
in the thymus or the environmental defect in periphery, 4610
6
sorted Ly5.1 wild-type peripheral T cells per mouse were retro-
orbitally transferred into Foxn1
D/D adult mice. One day later,
1 mg SEA per mouse was injected. The percentages of Vb3
bearing T cells of both host and donator were measured before
and after injection of SEA and shown as the ratio of percentage
(Fig. 7B). After 2 days of exposure to SEA, the percentage of
transferred Ly5.1 Vb3 bearing wild-type CD4 cells was increased
more than 2 fold, which reached a peak of 8 fold at day 4 and
then reduced. A similar result was showed in Ly5.1 wild-type
CD8 cells. The percentages of transferred Vb3 bearing CD4 and
CD8 clones did not increase in the absence of SEA injection,
indicating that the increase in transferred Vb3 bearing CD4 and
CD8 clones was not due to homeostatic proliferation. These
results suggest that the hypocellular peripheral environment
shapes the response of T cells to specific antigen. The host Vb3
bearing CD4 cells had a weaker response to SEA than transferred
Ly5.1 wild-type cells, although the magnitude of their response
was similar to that seen in panels A and B. This suggests that in
direct comparison to wild-type cells, the Foxn1
D/D peripheral T
cells have a weaker response to specific antigen. It is also possible
that the low expression of surface TCR on Foxn1
D/D T cells
resulted in a reduced ability to compete for limited antigen
stimulation in the same mouse.
Foxn1
D/D;OT1 TCR transgenic CD8 cells have a high
sensitivity response to OVA protein
To further investigate the abnormal response of the Foxn1
D/D T
cell, the Foxn1
D/D;OT1 Tg (marked as D/D;OT-Tg in Fig. 8) mice
were used to analyze the response of CD8 cells to OVA protein.
Serial doses of OVA protein were injected into Foxn1
D/D;OT1 Tg
and Foxn1
+/D;OT1 Tg (marked as +/D;OT-Tg in Fig. 8) mice. In
all experiments, the day of OVA injection was set as day 0. The
percentage of CD8
+;OT1 Tg cells was measured before and after
injection of OVA, and the change of percentage of CD8
+;OT1 Tg
cell was shown as a ratio. In Foxn1
+/D;OT1 Tg control mice,
CD8
+;OT1 Tg T cells expanded at day 2 after exposure to relative
high doses of OVA. Between day 2 and day 4 after injection of
OVA, the percentage of CD8
+;OT1 Tg cells dropped quickly, and
decreased to below the day 0 level after 4 days. The response was
dose dependent. For example, 20 mg OVA gave a 2-fold increase
analyzed in thymocyte (A, B, C and D) and splenocytes (E, F, G and H). A, representative profile of expression of CD4 and CD8 on thymocytes.
Histograms showing expression of KJ1-26 on gated CD4 SP thymocytes. B, the percentage of CD4 SP thymocytes in individual DO11.10 Tg and non-
Tg mice; C, individual analysis of percentage of KJ1-26
+ cells on gated CD4 SP thymocytes; D, total number of thymic cells number from individual
DO11.10 Tg and non-Tg mice. E, F, G and H show the same analyses performed on splenotytes. (*, p,0.05).
doi:10.1371/journal.pone.0015396.g003
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D/D;OT1 and Foxn1
D/D;OT1 Tg mice were
generated by mating Foxn1
D/D mice with OT1 CD8 TCR Tg mice, and the CD8 Tg cells were analyzed in thymocytes (A, B, C and D) and splenocytes (E,
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fold increase. Doses of OVA below 2 mg caused a decrease in the
percentage of CD8
+;OT1 Tg cells (Fig. 8A), as previously reported
[26,27]. In the Foxn1
D/D;OT1 Tg mice, a hypersensitive response
was seen in the CD8
+;OT1 Tg population. Doses of 0.5 mg were
enough to drive a dramatic expansion of CD8
+;OT1 Tg cells at
day 2 to a level higher than that seen with the 20 mg dose in
Foxn1
+/D;OT1 Tg control mice. This response lasted 2 days longer
than the response in Foxn1
+/D;OT1 Tg control mice, then fell to
the level of day 0 at day 6. At no dose did the CD8
+;OT1 Tg
population significantly decrease to below the level of day 0 in
Foxn1
D/D mice (Fig. 8B). Thus, the Foxn1
D/D;OT1 Tg T cells had a
hypersensitive proliferative response to low doses of antigen, and
never responded to antigen by with clonal deletion.
F, G and H). A, representative profile of CD4 and CD8 expression on thymocytes (top panel), and expression of Va2 and Vb5 on gated CD8 SP
thymocytes (bottom panel). B, percentage of CD8 SP thymocytes in individual OT1 Tg and non-Tg mice; C, individual analysis of the percentage of
Va2
+ and Vb5
+ cell on gated CD8 SP thymocytes; D, total number of thymic cells from individual OT1 Tg and non-Tg mice. E, F, G and H show the
same analyses performed on splenotytes. (*, p,0.05).
doi:10.1371/journal.pone.0015396.g004
Figure 5. Changes in MHCII and MHC I expression on Foxn1
D/D TECs. A, histograms showing representative profile of MHC II (left) and MHC I
(right) expression on gated CD45
2 thymic stromal cells from Foxn1
+/D and Foxn1
D/D mutant C57BL/6J mice. B, the percentage of MHC II
+ and MHC II
hi
cells (left), MHC I
+ and MHC I
hi cells (right) in gated CD45
2 thymic stromal cells from Foxn1
+/D and Foxn1
D/D mutant C57BL/6J mice. (*, p,0.05).
doi:10.1371/journal.pone.0015396.g005
Impaired Thymic Selection in Foxn1
D/D Mutant Mice
PLoS ONE | www.plosone.org 8 November 2010 | Volume 5 | Issue 11 | e15396We have previously shown that peripheral T cells in the
Foxn1
D/D mice have an activated/memory phenotype due to
lymphopenia-induced proliferation (LIP) [20]. To test whether
t h eh y p e r s e n s i t i v er e s p o n s eo fFoxn1
D/D;OT1 Tg CD8
+cells was
due in part to exposure to the lymphopenic environment of the
Foxn1
D/D mice, rather than to differences in intrathymic
development, we transferred CD8
+;OT1 Tg cells derived from
Foxn1
+/D;OT1 Tg mice into Foxn1
D/D mice that did not carry
the OT1 transgene (‘host’ in Fig. 8C–E). Two days later (Day 0)
we injected a low dose of OVA at 0.25 mg per mouse. As above,
t h ep e r c e n t a g eo fC D 8
+;OT1 Tg cells was measured before and
after injection of OVA, and the change of percentage of
CD8
+;OT1 Tg cells was shown as a ratio. As expected, host T
cells showed no change either in the presence or absence of
OVA over a 12-day period (Fig. 8C). The percentage of
transferred CD8
+;OT1 Tg cells increased at day 2 after
injection of OVA, and then reached a peak to 8 fold higher
than the level of day 0, consistent with an LIP response in the
hypocellular Foxn1
D/D peripheral environment [20]. In recipient
mice that were given injection of OVA, the percentage of
CD8
+;OT1 Tg cells increased more slowly and reached a lower
peak (3 fold increase) than with cell transfer alone. Our
interpretation of this result is that the expansion of CD8
+;OT1
Tg cells was driven by LIP, and that the low dose of 0.25 mg
O V Ai n d u c e ds o m el e v e lo fc l o n a ld e l e t i o ni nt h eC D 8
+;OT1
Tg, as it did in the Foxn1
+/D;OT1 Tg mice (Fig. 8A). If the OVA
had further stimulated the LIP effect, the percentage of
CD8
+;OT1 Tg cell should have been higher than the
percentage in the cell transfer control group (Fig. 8C). Thus,
with OVA challenge immediately after cell transfer, the
transferred CD8
+;OT1 Tg cells underwent clonal deletion in
response to the i.v. injection of OVA.
The possibility that we were inducing simultaneous LIP and
clonal deletion in the above experiment raised the issue of whether
we could separate the two responses. Another experiment was
performed which OVA was injected 12 days after CD8
+;OT1 Tg
cells were transferred. At this time, all the transferred CD8
+;OT1
Tg cells had already undergone LIP, and displayed a proliferating
status and were CD44
hi, but the percentage had returned to a level
similar to day 0 (Fig. 8C and data not shown). This situation was
therefore more similar to that of the host T cells in the Foxn1
D/D
mice [20]. In controls that received cells only, the percentage of
CD8
+;OT1 Tg cells did not change over the additional 12-day
period without OVA injection (Figure 8D). In contrast, after
injection of OVA the percentage of CD8
+;OT1 Tg cells increased
2 days later, with a overall profile similar to that seen with
injection of OVA soon after cell transfer (Figure 8C), rather than
undergoing deletion as seen in the Foxn1
+/D;OT1 Tg mice. This
result indicated that he response to OVA was dictated not by the
thymic environment in which they developed, but by the
peripheral environment in which they were exposed to OVA.
We interpret this result to mean that exposure to the lymphopenic
peripheral environment of the Foxn1
D/D mice and subsequent LIP-
induced development of a CD44
hi memory like phenotype
conferred to the transferred cells a hypersensitive response to
specific antigen.
Figure 6. SP thymocytes and splenocytes show immature surface phenotypes and incomplete activation upon stimulation with
anti-CD3. A, expression of HSA and Qa2 on thymocytes (left panel) and splenoytes (right panel) derived from NB, day 14 and day 28 Foxn1
+/D and
Foxn1
D/D mice. D, E and F, expression of CD25, CD69, CD44 on peripheral CD4 (left) and CD8 (right) T cells after stimulation with anti-CD3 for 9 and
24 hours in vitro. The results shown were the average from two individual experiments.
doi:10.1371/journal.pone.0015396.g006
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+CD25
+ regulatory T cells can partially suppress the
response of the Foxn1
D/D;OT1 Tg CD8
+ cells to OVA in
vivo
One possibility for the high response of CD8
+;OT1 Tg cells in
the Foxn1
D/D peripheral environment to OVA was the lack of
normal regulatory T cell (Treg) function in Foxn1
D/D mice [20]. To
address this issue, sorted CD4
+CD25
+ Treg cells from the
Foxn1
+/D control mice were transferred into the Foxn1
D/D;OT1
Tg mice together with i.v. injection of OVA at 0.4 mg per mouse,
an compared to injection of OVA or PBS alone. In the OVA only
group, the percentage of CD8
+;OT1 Tg cells increased as
expected (compare to Figure 8E with 8B). In the OVA plus Treg
group, the percentages of Tg CD8 cells were decreased comparing
to the percentage in OVA non-Treg cells group (Fig. 8E),
indicating that the co-injected Treg cells could suppress the
proliferative response to antigen. These results indicated that the
reduced function of CD4
+CD25
+ Treg cells in Foxn1
D/D might
contribute to the high response of CD8
+;OT1 Tg cells to OVA in
the Foxn1
D/D peripheral environment.
Discussion
Our previous work has shown that the thymic microenviron-
mental defects in the Foxn1
D/D mouse result in a variety of
secondary effects on thymocyte development and peripheral T cell
function [10,20,21]. The primary result from these previous
studies was that T cells in the Foxn1
D/D thymus developed from kit
negative progenitor cells via an atypical differentiation pathway.
Our current data further explore the mechanisms by which this
defective microenvironment influences thymocyte development,
specifically positive and negative selection, and how these defects
impact T cell function. We show that these atypical T cells have
surprisingly normal Vb usage, but significant defects in positive
and negative selection, especially for CD4
+ SP cells. Furthermore,
immature SP cells were able to exit the thymus prematurely.
These defects were exacerbated by peripheral lymphopenia caused
by the low thymic output, and the poor function of Treg cells
generated in the Foxn1
D/D mice. Thus, peripheral T cell
phenotypes were due to both primary defects in the thymic
Figure 7. Foxn1
D/D peripheral T cells have abnormal responses to SEA in vivo. A and B, showing kinetic response of Vb3 and Vb11 T cells to
SEA in vivo. Foxn1
+/D and Foxn1
D/D mice were retro-orbitally injected with SEA 1 mg per mouse, and the percentages of Vb3 and Vb11 were measured
in peripheral blood T cells on the indicated day. Y values show the ratio of percentages of Vb3
+ and Vb11
+ cell in individual day relative to day 0
(before injection of SEA). C and D, the response of transferred Ly5.1
+ cells to SEA in Foxn1
D/D mice. Sorted Ly5.1 T cells at 4610
6 per mouse were
transferred into Foxn1
D/D mice. One day later, the percentage of Vb3 was measured as day 0 and then SEA 1 mg per mouse was injected. The
percentage of Vb3 was continuously measured on the indicated days after injection of SEA and shown as the ratio of the percentage relative to day 0.
The results shown were the average from two or three individual experiments.
doi:10.1371/journal.pone.0015396.g007
Impaired Thymic Selection in Foxn1
D/D Mutant Mice
PLoS ONE | www.plosone.org 10 November 2010 | Volume 5 | Issue 11 | e15396microenvironment and secondary conditions in the peripheral
environment.
Canonical TCRab progenitors perform VDJ recombination
randomly after commitment, but positive selection for different Vb
may need continuous development of a variety of TECs [5]. In
spite of the severe defects in Foxn1
D/D TEC differentiation and the
lack of organized thymic compartments, we found that Vb usage
on peripheral T cells was largely similar to control mice. This
result suggested that these atypical progenitors had relatively
normal VDJ recombination of TCR Vb, that the severe TEC
defect in the Foxn1
D/D thymus did not significantly affect the ability
to support the process of TCRab commitment, and that there was
Figure 8. Foxn1
D/D;OT1 Tg CD8 cells have a high sensitivity response to OVA protein in Foxn1
D/D;OT1 Tg mice. All results are shown as a
ratio of the percentage of OT1Tg CD8 T cells on the indicated dayrelative to day 0. A andB, kinetic response of OT1Tg CD8 T cell to serial doses of OVA.
The Foxn1
+/D;OT1 Tg (+/D;OT-Tg) andFoxn1
D/D;OT1 Tg (D/D;OT-Tg) mice received a single retro-orbital injection of OVA from 0.06to 20 mg, and CD8 Tg
T cells in individual mice were analyzed at the indicated day. C and D, response of transferred Foxn1
+/D;OT1 Tg CD8 T cells to OVA in Foxn1
D/D mice.
2610
6 sorted Foxn1
+/D;OT1 Tg CD8 T cells were transferred into Foxn1
D/D mice. 1 day (C) and 10 days (D) later, the percentage of OT1 Tg CD8 cell was
measuredas day 0 andthen OVA250 mg permouse was injected. Thepercentage ofOT1TgCD8Tcells was continuously measuredattheindicatedday
after OVA injection. Results shown were the average volume from two or three individual experiments. E, the hypersensitive response of Foxn1
D/D;OT1
Tg CD8 T cells was partially suppressed by the transferred CD4
+CD25
+ regulatory T cells. Sorted CD4
+CD25
+ T cells were retro-orbitally transferred into
Foxn1
D/D;OT1 mice combining with OVA 400 mg per mouse. The results shown were the average volume from two individual experiments.
doi:10.1371/journal.pone.0015396.g008
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selection. However, the peripheral Vb repertoire was highly
variable between mice. This variability could reflect variability in
the differentiation and/or organization of the thymic environment
between different mutant mice. Alternatively, T cells with higher
affinity to MHC may undergo selective expansion via homeostatic
induced proliferation in the Foxn1
D/D lymphopenic periphery,
where MHCII expression should be normal. In the case of TCR
Vb5, this allele was reported to advantageously expand in
inflammatory bowl disease (IBD) [28,29]. As our previous data
also showed that some Foxn1
D/D mice showed autoimmune disease
symptoms including prolapse [20], the increased TCR Vb5
expression in the Foxn1
D/D periphery might be driven by an
autoimmune response.
While DCs are the major stromal cells that perform negative
selection at the cortical- medullary junction (CMJ) and in the
medulla, TECs can also contribute to this process [9]. In this
study, although the percentage of bone marrow derived DCs in
the Foxn1
D/D thymus was relatively increased, the capability of
negative selection was still lower in the mice compared to in the
Foxn1
+/D mice. This reduction of negative selection may be due to
the abnormal thymic architecture, with lack of both CMJ and
medulla in the Foxn1
D/D thymus, making it difficult for the SP
thymocytes to interact properly with DCs. In addition, the
reduction in negative selection could be secondary to premature
exit of immature T cells from the thymus. In the normal thymus,
SP thymocytes undergo maturation in the medulla for 10–14 days,
during which time the expression level of HSA is down-regulated,
and Qa2 is gradually up-regulated [24,30,31]. We found that the
SP thymocytes and splenocytes expressed a higher percentage of
HSA
hi and lower percentage of Qa2
+ in newborn and day 14
Foxn1
D/D mice. Consistent with the immature phenotype of
Foxn1
D/D peripheral T cells, some CD4
+ T cells couldn’t
completely be activated under anti CD3 stimulation in vitro,
although the CD8
+ T cells appeared more normal than CD4 T
cells (Fig. 5D). Other work in our lab has shown that the thymic
vasculature in Foxn1
D/D mice does not form properly, including
inability to retain FITC-dextran (JL Bryson, et al., in preparation).
This functional deficit combined with the lack of an organized
medulla could combine to result in HSA
hi immature cells
migrating out of the thymus prematurely in Foxn1
D/D mice. Thus,
the Foxn1
D/D thymus is both inefficient at generating mature SP
cells and unable to retain the resulting immature cells in the
thymus, resulting in immature and autoreactive T cells in the
periphery.
Positive selection of CD4 TCRab thymocytes is completely
dependent on MHC II expressing TEC, while the development of
CD8 thymocytes can be supported by MHC I on both TEC and
other thymic stromal cells in thymus [32,33,34]. In Foxn1
D/D
thymus, the positive selection for CD4 transgenic T cells was
dramatically damaged, while the selection for CD8 transgenic T
cells was less affected (Fig. 3, 4). This difference between CD4 and
CD8 is consistent with the greatly reduced expression of MHC II
on TECs, while MHC I was almost normal in the Foxn1
D/D
thymus [10], (Fig. 5). This result was also consistent with our data
from another Foxn1 mutant, Foxn
lacz, in which Foxn1 expression is
gradually down-regulated after birth. In these mice, MHC II
expression on TECs and production of CD4 T cells was reduced,
but CD8 T cells appeared normal [18]. The CD1 molecule was
reported to support CD4 positive selection in MHC II
2/2 mice
[35]. CD1 expression was normal in Foxn1
D/D thymus (data not
shown), suggesting that it might support some positive selection for
CD4 T cells in Foxn1
D/D mice. Alternatively, the reduced positive
selection could be due in part to an inability of the thymocytes
themselves to respond to selection signals, either due to prior
developmental deficits, or to intrinsic qualities based on their
differentiation from an atypical progenitor cell [20].
These intrathymic defects in T cell differentiation and selection
gave rise to peripheral T cells with defects in in vivo antigen-specific
response. The antigen-specific response in vivo is a complicated
process. Multiple facts may affect the process such as the dose of
antigen, preparation of antigen, usage of adjuvant, the
way of giving antigen, animal age and immune status
[26,27,36,37,38,39]. For example, oral feeding of antigen may
result in tolerance through anergy [39]; intravenous injection of
antigen may delete antigen specific T cells rapidly, with remaining
cells hyporesponsive; while the subcutaneous injection of antigen
may delete antigen specific T cells, with the remain cells
hypersensitive [36]. Both low and high dose antigen can result
in tolerance, but low dose of antigen results in anergy or clone
deletion, while high dose of antigen results in active suppression of
antigen specific T cells [26,27]. During antigen specific tolerance,
the CD25
+CD4
+ T regulatory cells that develop in the thymus
play an important role in the process of tolerance and immune
balance [38,40]. In Foxn1
D/D mice, the peripheral T cells had an
abnormal response to specific antigens; CD4 T cells showed a
delayed and strong response to SEA, while CD8 T cells had a
delayed but weaker response compared to the same cells in the
Foxn1
+/D mice (Fig. 7), or to that reported in wild-type mice [41].
Both intrathymic and peripheral defects could contribute to the
abnormal antigen response of Foxn1
D/D T cells: 1) the deficient
thymic environment, including the down-regulation of MHC II on
TEC, might preferentially select the higher avidity T cells, and
these cells could not be deleted by negative selection; 2) the
abnormally lymphopenic peripheral environment causes lympho-
penia induced proliferation (LIP) [20]; this could cause some
clones with a higher avidity to be advantageously expanded in the
Foxn1
D/D periphery; 3) since CD4
+CD25
+ regulatory T cells
played a key role in antigen specific tolerance in vivo [38,40,42],
some phenotypes could result from the reduced function of
CD4
+CD25
+ regulatory T cells in the Foxn1
D/D mice [20]; and 4)
constitutively low TCR expression on Foxn1
D/D T cells may reduce
the response to antigen [21]. The mutant-like response to SEA of
wild-type or OT-1 transgenic SP T cells transferred in Foxn1
D/D
mice (Fig. 7) implicates the peripheral environment, rather than
the development in an abnormal thymic microenvironment, in this
abnormal response. Furthermore, we showed that wild-type
CD4
+CD25
+ regulatory T cells transferred into Foxn1
D/D mice
could partially inhibit the strong response (Fig. 8E). Taken
together, our results suggest that that the Foxn1
D/D lymphopenic
environment and the lack of normal function of CD4
+CD25
+
regulatory T cells were the major reasons for the hypersensitive
response in the Foxn1
D/D mice.
Taken together, our results show that both deficient develop-
ment of T cells in the thymus and an abnormal antigen specific
response in the periphery contribute to the phenotype of
peripheral T cells in Foxn1
D/D mice. Further analysis on this
experimental system may be useful for the studies of clinical
immune tolerance or vaccine immune response in humans with
immune deficient disease.
Materials and Methods
Mice and treatment
Foxn1
D/D mutant mice generated in our laboratory were
described previously [10]. The mice were of a mixed C57BL/6J
and 129SvJ background. BL/6-Ly5.1 mice, BALB/c mice,
DO11.10 and OT1 TCR-transgenic mice were obtained from
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PCR. Foxn1
D/D;BALB/c mice were generated by backcrossing
Foxn1
D/D mice (H-2
b,I E
-) with BALB/c (H-2
d,I E
+) for more than
5 generations. To control for the H-2
d background, a pair of
primers that are linkage marker D17MIT22 for H-2 IA and IE
genes were used for genotypic PCR analysis. This primer pair
produces a 157 bp fragment for the C57BL/6 allele, and a
183 bp-sized fragment from BALB/c allele. Foxn1
D/D;DO11.10
Tg and Foxn1
D/D;OT1 Tg mice were generated by mating Foxn1
D/
D;BALB/c mice with DO11.10 mice and Foxn1
D/D mice with OT1
mice, respectively. For testing the response of Vb T cell clones to
superantigen, mice were retro-orbitally injected with a single dose
of 1 mg SEA (Staphylococcal Enterotoxin A, Sigma-Aldrich) per
mouse, in 200 ml PBS. For response of OT1 Tg CD8 cells to OVA
protein (Sigma, Steinheim, Germany, MW:44.287 Da), mice
received single retro-orbital injections of a serial dose range from
0.06 to 20 mg in 200 ml PBS. All the mice were maintained in a
specific pathogen-free (SPF) facility at University of Georgia;
experiments were approved by the University of Georgia’s
Institutional Animal Care and Use Committee. The internal
IACUC approval number currently is A2008-10181.
Flow Cytometry Analysis and Antibodies
Splenocyte and thymocyte cell suspensions were prepared and
counted for total cell numbers. Blood samples were taken by retro-
orbital bleed on the indicated day; 50–100 ml blood was collected
and blood mononuclear cells were isolated by density gradient
centrifugation and lysis of RBC. All blood mononuclear cells and
0.5–1610
6 thymocytes or splenocytes were stained with the
following mAbs conjugated to PE, FITC, allophycocyanin directly,
or Biotin-labeled mAbs, followed by Strepavidin-PerCP: Mouse
TCR Vb screening panel, anti-CD4 (RM4-5), anti-CD8a (53-6.7),
anti-CD45.1 (A20), anti-CD45.2 (104), anti-CD3e (145-2c11),
anti-HSA (M1/69), and anti-Qa2 (H-2), anti-Kj1-26, anti-Vb3
(Kj25), anti-Vb5.1,5.2 (MR9-4), anti-Vb11 (RR3-15), and anti-
Va2 (B20.1) anti-CD44 (IM7), anti-CD25 (7D4), anti-CD69
(H1.2F3), (all Abs from BD Pharmingen, San Diego, CA).
For the staining of MHCI and MHCII on CD45
- thymic
stromal cells (TSC), thymic lobes were cut and washed in RPMI
1640+2%FBS medium to deplete most thymocytes, thymic
fragments were then digested by collagenase/dispase (1 mg/ml,
Roche Applied Science) plus DNase I (5 mg/ml) in RPMI 1640
plus 2%FBS medium for 1–1.5 hours at 37uC bath. The enriched
TSCs were then stained with anti-CD45-allophycocyamin (30-
F11), anti-MHCI H-2Kb PE (AF6-88.5), and MHCII I-A/I-E
FITC (M5/114.15.2) (Biolegend). Anti-CD16/32 (2.4G2) (Biole-
gend or BD Pharmingen) and Rat-serum were used to block FC-
receptors before staining. Three- or four-color immunofluores-
cence analysis was performed using a FACSCalibur system. The
data were analyzed using CellQuest software (Becton Dickson,
Franklin Lake, NJ).
Activation of peripheral T cells by anti-CD3 antibody in
vitro
26106 peripheral lymphocytes prepared from spleen and LNs
were plated in 24-well plates previously coated with 10 mg/ml of
anti-CD3e Ab and cultured for 24 h. As a control, cells were
cultured in media alone. Cells were harvested after 9 and 24 hour
culture and stained with anti-CD4, anti-CD8, and anti-CD44,
anti-25 and anti-CD69 markers, then placed in FACS store
solution for analysis by flow cytometry.
Adoptive transfer
Peripheral lymphocyte suspensions were prepared from freshly
isolated spleen and lymph nodes from C57BL6/J Ly5.1 or OT1
donor mice and further isolated by density gradient centrifugation
and lysis of RBC in ACK lysis buffer (Cambrex Bio Science,
Walkersville, MD). Around 4610
6 cells were transferred into
Foxn1
D/D mice. For isolation of T regulatory cells, peripheral
lymphocyte suspension from Foxn1
+/D mice was stained by anti-
CD4 PE and anti-CD25 allophycocyanin mAbs, then sorted by
MoFlo FACS (DakoCytomation). 2610
5 T regulatory cells per
mice were transferred into Foxn1
D/D mice.
Acknowledgments
We thank Dr. Ellen R. Richie (University of Texas, MD Anderson Cancer
Center, Science Park Research Division, Smithville, TX) and Dr. Lauren
Ehrlich (University of Texas, Austin TX) for reading the manuscript, and
Julie Nelson (University of Georgia, Center for Tropical and Emerging
Global Diseases Flow Cytometry Facility, Athens, GA) for help with cell
sorting.
Author Contributions
Conceived and designed the experiments: SX. Performed the experiments:
SX. Analyzed the data: SX. Contributed reagents/materials/analysis tools:
SX. Wrote the paper: SX NRM.
References
1. Jameson SC, Bevan MJ (1998) T-cell selection. Curr Opin Immunol 10:
214–219.
2. Anderson G, Jenkinson EJ (2001) Lymphostromal interactions in thymic
development and function. Nat Rev Immunol 1: 31–40.
3. Hugo P, Kappler JW, Godfrey DI, Marrack PC (1992) A cell line that can
induce thymocyte positive selection. Nature 360: 679–682.
4. Anderson G, Owen JJ, Moore NC, Jenkinson EJ (1994) Thymic epithelial cells
provide unique signals for positive selection of CD4+CD8+ thymocytes in vitro.
J Exp Med 179: 2027–2031.
5. DeKoning J, DiMolfetto L, Reilly C, Wei Q, Havran WL, et al. (1997) Thymic
cortical epithelium is sufficient for the development of mature T cells in relB-
deficient mice. J Immunol 158: 2558–2566.
6. Cosgrove D, Chan SH, Waltzinger C, Benoist C, Mathis D (1992) The thymic
compartment responsible for positive selection of CD4+ T cells. Int Immunol 4:
707–710.
7. Laufer TM, DeKoning J, Markowitz JS, Lo D, Glimcher LH (1996) Unopposed
positive selection and autoreactivity in mice expressing class II MHC only on
thymic cortex. Nature 383: 81–85.
8. Anderson G, Jenkinson EJ, Moore NC, Owen JJ (1993) MHC class II-positive
epithelium and mesenchyme cells are both required for T-cell development in
the thymus. Nature 362: 70–73.
9. Jenkinson EJ, Anderson G, Owen JJ (1992) Studies on T cell maturation on
defined thymic stromal cell populations in vitro. J Exp Med 176: 845–
853.
10. Su DM, Navarre S, Oh WJ, Condie BG, Manley NR (2003) A domain of Foxn1
required for crosstalk-dependent thymic epithelial cell differentiation. Nat
Immunol 4: 1128–1135.
11. Blackburn CC, Augustine CL, Li R, Harvey RP, Malin MA, et al. (1996) The nu
gene acts cell-autonomously and is required for differentiation of thymic
epithelial progenitors. Proc Natl Acad Sci USA 93: 5742–5746.
12. Nehls M, Kyewski B, Messerle M, Waldschutz R, Schuddekopf K, et al. (1996)
Two genetically separable steps in the differentiation of thymic epithelium.
Science 272: 886–889.
13. Nehls M, Pfeifer D, Schorpp M, Hedrich H, Boehm T (1994) New member of
the winged-helix protein family disrupted in mouse and rat nude mutations.
Nature 372: 103–107.
14. Shakib S, Desanti GE, Jenkinson WE, Parnell SM, Jenkinson EJ, et al. (2009)
Checkpoints in the development of thymic cortical epithelial cells. J Immunol
182: 130–137.
15. Gordon J, Wilson VA, Blair NF, Sheridan J, Farley A, et al. (2004) Functional
evidence for a single endodermal origin for the thymic epithelium. Nat Immunol
5: 546–553.
Impaired Thymic Selection in Foxn1
D/D Mutant Mice
PLoS ONE | www.plosone.org 13 November 2010 | Volume 5 | Issue 11 | e1539616. Itoi M, Kawamoto H, Katsura Y, Amagai T (2001) Two distinct steps of
immigration of hematopoietic progenitors into the early thymus anlage. Int
Immunol 13: 1203–1211.
17. Itoi M, Tsukamoto N, Amagai T (2007) Expression of Dll4 and CCL25 in
Foxn1-negative epithelial cells in the post-natal thymus. Int Immunol 19:
127–132.
18. Chen L, Xiao S, Manley NR (2009) Foxn1 is required to maintain the postnatal
thymic microenvironment in a dosage-sensitive manner. Blood 113: 567–574.
19. Ortman CL, Dittmar KA, Witte PL, Le PT (2002) Molecular characterization of
the mouse involuted thymus: aberrations in expression of transcription
regulators in thymocyte and epithelial compartments. Int Immunol 14: 813–822.
20. Xiao S, Su DM, Manley NR (2008) T cell development from kit-negative
progenitors in the Foxn1Delta/Delta mutant thymus. J Immunol 180: 914–921.
21. Xiao S, Su DM, Manley NR (2007) Atypical memory phenotype T cells with
low homeostatic potential and impaired TCR signaling and regulatory T cell
function in Foxn1Delta/Delta mutant mice. J Immunol 179: 8153–8163.
22. Kappler JW, Roehm N, Marrack P (1987) T cell tolerance by clonal elimination
in the thymus. Cell 49: 273–280.
23. Saijo K, Park SY, Ishida Y, Arase H, Saito T (1997) Crucial role of Jak3 in
negative selection of self-reactive T cells. J Exp Med 185: 351–356.
24. Scollay R, Godfrey DI (1995) Thymic emigration: conveyor belts or lucky dips?
Immunol Today 16: 268–273; discussion 273-264.
25. McCaughtry TM, Wilken MS, Hogquist KA (2007) Thymic emigration
revisited. J Exp Med 204: 2513–2520.
26. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, et al. (1995) Peripheral
deletion of antigen-reactive T cells in oral tolerance. Nature 376: 177–180.
27. Kurts C, Sutherland RM, Davey G, Li M, Lew AM, et al. (1999) CD8 T cell
ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad
Sci U S A 96: 12703–12707.
28. Bateman HE, Kirou KA, Paget SA, Crow MK, Yee AM (1999) Remission of
juvenile rheumatoid arthritis after infection with parvovirus B19. J Rheumatol
26: 2482–2484.
29. Peacock CD, Kim SK, Welsh RM (2003) Attrition of virus-specific memory
CD8+ T cells during reconstitution of lymphopenic environments. J Immunol
171: 655–663.
30. Fowlkes BJ, Schweighoffer E (1995) Positive selection of T cells. Curr Opin
Immunol 7: 188–195.
31. Kishimoto H, Sprent J (1997) Negative selection in the thymus includes
semimature T cells. J Exp Med 185: 263–271.
32. Vukmanovic S, Grandea AG, 3rd, Faas SJ, Knowles BB, Bevan MJ (1992)
Positive selection of T-lymphocytes induced by intrathymic injection of a thymic
epithelial cell line. Nature 359: 729–732.
33. Pawlowski T, Elliott JD, Loh DY, Staerz UD (1993) Positive selection of T
lymphocytes on fibroblasts. Nature 364: 642–645.
34. Hugo P, Kappler JW, McCormack JE, Marrack P (1993) Fibroblasts can induce
thymocyte positive selection in vivo. Proc Natl Acad Sci U S A 90:
10335–10339.
35. Cardell S, Tangri S, Chan S, Kronenberg M, Benoist C, et al. (1995) CD1-
restricted CD4+ T cells in major histocompatibility complex class II-deficient
mice. J Exp Med 182: 993–1004.
36. Kearney ER, Pape KA, Loh DY, Jenkins MK (1994) Visualization of peptide-
specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:
327–339.
37. Zhang X, Izikson L, Liu L, Weiner HL (2001) Activation of CD25(+)CD4(+)
regulatory T cells by oral antigen administration. J Immunol 167: 4245–4253.
38. Thorstenson KM, Khoruts A (2001) Generation of anergic and potentially
immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral
tolerance with intravenous or oral antigen. J Immunol 167: 188–195.
39. Sun JB, Mielcarek N, Lakew M, Grzych JM, Capron A, et al. (1999) Intranasal
administration of a Schistosoma mansoni glutathione S-transferase-cholera
toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in
mice. J Immunol 163: 1045–1052.
40. Yamazaki S, Inaba K, Tarbell KV, Steinman RM (2006) Dendritic cells expand
antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors
of alloreactivity. Immunol Rev 212: 314–329.
41. McCormack JE, Kappler J, Marrack P (1994) Stimulation with specific antigen
can block superantigen-mediated deletion of T cells in vivo. Proc Natl Acad
Sci U S A 91: 2086–2090.
42. Winstead CJ, Fraser JM, Khoruts A (2008) Regulatory CD4+CD25+Foxp3+ T
cells selectively inhibit the spontaneous form of lymphopenia-induced prolifer-
ation of naive T cells. J Immunol 180: 7305–7317.
Impaired Thymic Selection in Foxn1
D/D Mutant Mice
PLoS ONE | www.plosone.org 14 November 2010 | Volume 5 | Issue 11 | e15396